|
DNAJC21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.107699999503E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88790000024797E-07 |
| Normal-vs-Stage2 |
9.224000E-04 |
| Normal-vs-Stage3 |
1.366430E-01 |
| Normal-vs-Stage4 |
3.863600E-02 |
| Stage1-vs-Stage2 |
8.554800E-01 |
| Stage1-vs-Stage3 |
1.036560E-01 |
| Stage1-vs-Stage4 |
9.759600E-01 |
| Stage2-vs-Stage3 |
1.037610E-01 |
| Stage2-vs-Stage4 |
8.782400E-01 |
| Stage3-vs-Stage4 |
2.650200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17919999717853E-08 |
| Normal-vs-AfricanAmerican |
7.445900E-04 |
| Normal-vs-Asian |
2.712800E-01 |
| Caucasian-vs-AfricanAmerican |
5.464600E-01 |
| Caucasian-vs-Asian |
7.480800E-01 |
| AfricanAmerican-vs-Asian |
9.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0101997016676E-10 |
| Normal-vs-Female |
5.837600E-01 |
| Male-vs-Female |
9.88339999999921E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.623250E-03 |
| Normal-vs-Extreme_Weight |
3.57670004724753E-10 |
| Normal-vs-Obese |
7.958600E-03 |
| Normal-vs-Extreme_Obese |
1.652420E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.309000E-01 |
| Normal_Weight-vs-Obese |
5.876800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.228400E-01 |
| Extreme_Weight-vs-Obese |
5.350000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.986000E-01 |
| Obese-vs-Extreme_Obese |
2.939600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.143850E-01 |
| Normal-vs-Age(41-60Yrs) |
1.67260999999197E-05 |
| Normal-vs-Age(61-80Yrs) |
9.6103000002401E-08 |
| Normal-vs-Age(81-100Yrs) |
2.560100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.577200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.532600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.390000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.640600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.098400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.96365187735637E-12 |
| Normal-VS-Type2 PRCC |
1.161230E-01 |
| Normal-VS-KIRP CIMP |
2.773200E-01 |
| Normal-VS-Unclassified PRCC |
1.566180E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.642400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.532500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.634100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.865600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.816800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.752000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51191999999689E-05 |
| Normal-vs-N1 |
2.879200E-01 |
| Normal-vs-N2 |
1.631560E-01 |
| N0-vs-N1 |
2.536200E-02 |
| N0-vs-N2 |
9.428600E-01 |
| N1-vs-N2 |
2.405000E-01 |
|
|
